Curated News
By: NewsRamp Editorial Staff
September 06, 2024
Assisted Reproductive Technology Testing Outcomes During COVID Travel Lockdown
TLDR
- HIV-infected men pursued semen testing for fertility procedures, resulting in 32 reported pregnancies and 43 babies born.
- BFR conducts stem cell and related research including patient-specific stem cells, circadian rhythm impact on embryo development, and prostate cancer screening.
- The research contributes to curing HIV disease, spinal cord injury, and creating accurate tests for prostate cancer, ultimately improving lives.
- The research findings include breakthroughs in stem cell therapies, embryo development, and educational events for sharing research information.
Impact - Why it Matters
This news matters as it highlights the successful outcomes of assisted reproductive technology testing for couples with infectious disease infertility during the COVID travel lockdown. It also showcases the valuable work of the Bedford Research Foundation in conducting stem cell and related research for currently incurable diseases.
Summary
A summary of assisted reproductive technology testing needs and outcomes during COVID travel lockdown (April, 2020 to March 7, 2022) for couples with infectious disease infertility. One hundred fifty six HIV-infected men from 12 countries pursued semen testing for fertility procedures, 82 gestational carriers and wives underwent embryo transfer without infection, 32 pregnancies from nine fertility clinics were reported and a total of 43 babies were born to gestational carriers and wives during that two year period. The Bedford Research Foundation (BRF) is a biomedical institute conducting stem cell and related research for diseases presently considered incurable. The foundation conducts research, educational events, laboratory products and services, and educational media.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, Assisted Reproductive Technology Testing Outcomes During COVID Travel Lockdown